Individuals with depression and elevated peripheral inflammatory markers, included albuminuria, might have benefit of anti-inflammatory agents, such as acetyl-salicylic acid (ASA), statins, ACE inhibitors and ATB to improve the treatment of depression and other mood disorders, leading to reduction of disability, even though there is much more research to be carried out here. This evidence concerns the gene ACE and depressive disorder.